The Chief Executive Officer of Lucid Diagnostics Inc. (associated with the Nasdaq stock ticker LUCD) is Dr. Lishan Aklog, who has guided the enterprise since its formative stages. A trained cardiothoracic surgeon and medical technology entrepreneur, he oversees corporate governance, clinical trial strategies, and commercial expansion efforts aimed at establishing early esophageal cancer screening as a standard component of preventative healthcare.